Hormosan Pharma GmbH
Daniel Drogan is currently the Device Manager for Medicine Products at Hormosan Pharma GmbH. Prior to this role, Daniel held positions such as IVDR Project Lead at ORGENTEC Diagnostika GmbH and Regulatory Affairs Manager at Aesku.Diagnostics GmbH & Co. KG. Daniel has a background in Bioinformatics and Biotechnology from FH Bingen and FH Lausitz, respectively. Daniel has also undergone various training programs and has experience in leadership, regulatory affairs, product development, and virology research.
This person is not in the org chart
This person is not in any teams
Hormosan Pharma GmbH
Hormosan was founded in Germany over 50 years ago and ever since has developed successfully into a mid-sized pharmaceutical company. Today we market a large portfolio spanning from innovative medicines to generics and we focus on three core therapeutic areas: Rare diseases in neurology Pain therapy for chronic pain and headaches Sexual health with focus on oral contraceptives, erectile dysfunction and HIV With our innovative medicines we address so far unmet needs of our patients. Specific formulations or dosage forms of our specialty-like medications enhance patient benefits and compliance. And with our generics we provide high quality therapeutic options with attractive pricing. 2008 Hormosan was acquired by the international pharmaceutical LUPIN Group. Being embedded in this global network also continuously drives our competitiveness which is the fundament for us to provide long-term attractive therapeutic options to patients in the German market.